Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	148	253	259	453	591	359
Market Cap Growth	13.23%	-2.48%	-42.79%	-23.38%	64.89%	-6.41%
Enterprise Value	159	256	243	359	573	297
PE Ratio	-	-10.08	-4.43	-25.30	-19.88	-5.36
PS Ratio	1.23	2.16	2.16	3.04	5.45	6.05
PB Ratio	-8.19	-8.83	-19.04	14.92	17.38	6.67
P/FCF Ratio	-38.81	-46.10	-3.54	86.30	-11.07	-8.35
P/OCF Ratio	-38.84	-44.03	-3.51	77.10	-11.33	-8.64
EV/Sales Ratio	1.32	2.19	2.02	2.40	5.28	5.01
EV/EBITDA Ratio	-24.64	-15.10	-4.50	-31.79	-20.70	-4.51
EV/EBIT Ratio	-22.06	-14.08	-4.42	-28.82	-20.19	-4.46
EV/FCF Ratio	-40.45	-46.77	-3.31	68.32	-10.72	-6.91
Debt / Equity Ratio	-1.91	-2.11	-3.05	1.01	1.15	0.67
Debt / EBITDA Ratio	-5.51	-3.57	-0.77	-2.71	-1.41	-0.55
Debt / FCF Ratio	-9.05	-11.05	-0.57	5.82	-0.73	-0.85
Quick Ratio	1.05	1.64	1.51	2.21	1.79	1.86
Current Ratio	1.26	1.86	1.78	2.43	2.18	2.04
Asset Turnover	1.01	0.99	0.91	0.77	0.84	0.38
Interest Coverage	-1.63	-2.65	-14.80	-2.56	-20.98	-198.68
Return on Equity (ROE)	65.90%	88.90%	772.50%	-31.60%	-52.50%	-90.30%
Return on Assets (ROA)	-16.60%	-21.20%	-44.50%	-9.30%	-23.10%	-42.30%
Return on Capital (ROIC)	-51.10%	-64.16%	-198.84%	-20.51%	-39.63%	-76.66%
Earnings Yield	-13.39%	-9.92%	-22.59%	-3.95%	-5.03%	-18.65%
FCF Yield	-4.52%	-2.17%	-28.28%	1.16%	-9.04%	-11.98%
Buyback Yield / Dilution	-0.94%	-0.93%	-1.12%	-1.03%	-0.81%	-4.28%
Total Shareholder Return	-0.94%	-0.93%	-1.12%	-1.03%	-0.81%	-4.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).